New CRA funding for Team 3
Publication date: 4 May 2022

Team 3 is a partner in a programme labelled by the ARC, and supported by B. Malissen (CIML)The project is focused on the functional optimisation of human anti-tumour T cells through the proteomic analysis of their inhibitory immunoreceptors.

Discover the projects of Team 3